Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Clin Cancer Res. 2009 Feb 15;15(4):1443–1451. doi: 10.1158/1078-0432.CCR-08-1231

Fig. 2.

Fig. 2

Fig. 2

Fig. 2

Fig. 2

PFS and OS by treatment (n = 115) and PFS by treatment (n = 115). 1, A, progression of survival of patients according to treatment with IFN-α2b; B, progression of survival of patients according to treatment with GM-CSF. OS by treatment (n = 115). 2, A, OS by treatment with IFN-α2b; B, OS by treatment with GM-CSF.